These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Expanding newborn screening for lysosomal disorders: opportunities and challenges. Waggoner DJ; Tan CA Dev Disabil Res Rev; 2011; 17(1):9-14. PubMed ID: 22447749 [TBL] [Abstract][Full Text] [Related]
6. Musculoskeletal manifestations of Fabry disease: A retrospective study. Lidove O; Zeller V; Chicheportiche V; Meyssonnier V; Sené T; Godot S; Ziza JM Joint Bone Spine; 2016 Jul; 83(4):421-6. PubMed ID: 26697993 [TBL] [Abstract][Full Text] [Related]
7. The future of newborn screening for lysosomal disorders. Wasserstein MP; Orsini JJ; Goldenberg A; Caggana M; Levy PA; Breilyn M; Gelb MH Neurosci Lett; 2021 Aug; 760():136080. PubMed ID: 34166724 [TBL] [Abstract][Full Text] [Related]
8. Patients' perspectives on newborn screening for later-onset lysosomal storage diseases. Lisi EC; Gillespie S; Laney D; Ali N Mol Genet Metab; 2016 Sep; 119(1-2):109-14. PubMed ID: 27591925 [TBL] [Abstract][Full Text] [Related]
9. Newborn Screening for Lysosomal Storage Disorders. Anderson S J Pediatr Health Care; 2018; 32(3):285-294. PubMed ID: 29678259 [TBL] [Abstract][Full Text] [Related]
10. Lysosomal storage disorders in the newborn. Staretz-Chacham O; Lang TC; LaMarca ME; Krasnewich D; Sidransky E Pediatrics; 2009 Apr; 123(4):1191-207. PubMed ID: 19336380 [TBL] [Abstract][Full Text] [Related]
11. Newborn screening for six lysosomal storage disorders in a cohort of Mexican patients: Three-year findings from a screening program in a closed Mexican health system. Navarrete-Martínez JI; Limón-Rojas AE; Gaytán-García MJ; Reyna-Figueroa J; Wakida-Kusunoki G; Delgado-Calvillo MDR; Cantú-Reyna C; Cruz-Camino H; Cervantes-Barragán DE Mol Genet Metab; 2017 May; 121(1):16-21. PubMed ID: 28302345 [TBL] [Abstract][Full Text] [Related]
12. Lysosomal storage disorders in Thailand: the Siriraj experience. Wasant P; Wattanaweeradej S; Raksadawan N; Kolodny EH Southeast Asian J Trop Med Public Health; 1995; 26 Suppl 1():54-8. PubMed ID: 8629143 [TBL] [Abstract][Full Text] [Related]
13. Immunochemistry of lysosomal storage disorders. Parkinson-Lawrence E; Fuller M; Hopwood JJ; Meikle PJ; Brooks DA Clin Chem; 2006 Sep; 52(9):1660-8. PubMed ID: 16840586 [TBL] [Abstract][Full Text] [Related]
14. Newborn screening of lysosomal storage disorders. Marsden D; Levy H Clin Chem; 2010 Jul; 56(7):1071-9. PubMed ID: 20489136 [TBL] [Abstract][Full Text] [Related]
15. Current Status and Use of Resources of Lysosomal Storage Diseases: Analysis of a Spanish Claims Database. Darbà J; Marsà A Endocr Metab Immune Disord Drug Targets; 2020; 20(2):263-270. PubMed ID: 31389322 [TBL] [Abstract][Full Text] [Related]
16. Newborn screening for lysosomal storage disorders. Meikle PJ; Grasby DJ; Dean CJ; Lang DL; Bockmann M; Whittle AM; Fietz MJ; Simonsen H; Fuller M; Brooks DA; Hopwood JJ Mol Genet Metab; 2006 Aug; 88(4):307-14. PubMed ID: 16600651 [TBL] [Abstract][Full Text] [Related]
17. The relative frequency of lysosomal storage disorders: a medical genetics referral laboratory's experience from India. Kadali S; Kolusu A; Gummadi MR; Undamatla J J Child Neurol; 2014 Oct; 29(10):1377-82. PubMed ID: 24700663 [TBL] [Abstract][Full Text] [Related]